Christopher J. Scoggins serves as Executive at ABBOTT LABORATORIES, where they oversee executive responsibilities. Since joining the company, Christopher J. Scoggins has executed 14 insider transactions totaling $5.7M, demonstrating a bearish approach to their equity position. Their most recent transaction on Feb 24, 2026 involved receiving (via award) 76,273 shares valued at $0.
Christopher J. Scoggins currently holds 76,273 shares of ABBOTT LABORATORIES (ABT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Christopher J. Scoggins has been a net seller of ABT stock. They have purchased $0 and sold $5.7M worth of shares.
Christopher J. Scoggins's most recent insider trade was on Feb 24, 2026, when they sold 76,273 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Apr 1, 2021 | ABT | $146.6K | Payment | 1,223 | $119.84 | Discretionary |
| Feb 26, 2021 | ABT | $589.2K | Payment | 4,846 | $121.58 | Discretionary |
| Feb 19, 2021 | ABT | $0 | Award | 12,484 | $N/A | Discretionary |
| Feb 1, 2021 | ABT | $576.0K | Option Exercise | 15,000 | $38.40 | Discretionary |
| Feb 1, 2021 | ABT | $5.5M | Sale | 45,000 | $123.24 | Discretionary |
| Feb 1, 2021 | ABT | $1.4M | Option Exercise | 30,000 | $48.04 | Discretionary |
| Apr 21, 2020 | ABT | $39.8K | Sale | 414 | $96.10 | Discretionary |
| Apr 1, 2020 | ABT | $82.7K | Payment | 1,048 | $78.91 | Discretionary |
| Mar 2, 2020 | ABT | $96.6K | Sale | 1,240 | $77.89 | Discretionary |
| Feb 28, 2020 | ABT | $191.6K | Payment | 2,420 | $79.19 | Discretionary |
| Feb 21, 2020 | ABT | $0 | Award | 11,250 | $N/A | Discretionary |
| Apr 1, 2019 | ABT | $0 | Award | 8,278 | $N/A | Discretionary |